References
- Serra L, Bautista I. Etiology of obesity: two “key issues” and other emerging factors. Nutr Hosp. 2013;28:32–43.
- Barquera S, Campos I, Hearnandes L, et al. Obesity and central adiposity in Mexican adults: results from the Mexican national health and nutrition survey 2006. Salud Publica Mex. 2006;51:S595–S603.
- DiBonaventura MD, Meincke H, Le Lay A, Fournier J, Bakker E, Ehrenreich A. Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences. Diabetes Metab Syndr Obes. 2017;11:1–10. doi:10.2147/DMSO.S129247
- Hotamisligil GS, Bernlohr DA. Metabolic functions of FABPs–mechanisms and therapeutic implications. Nat Rev Endocrinol. 2015;11(10):592–605. doi:10.1038/nrendo.2015.122
- Hotamisligil GS. Inflammation and metabolic disorders. Nat. 2006;444(7121):860–867. doi:10.1038/nature05485
- Cnop M, Landchild MJ, Vidal J, et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes. 2002;51(4):1005–1015. doi:10.2337/diabetes.51.4.1005
- Wagenknecht LE, Langefeld CD, Scherzinger AL, et al. Insulin sensitivity, insulin secretion, and abdominal fat: the insulin resistance atherosclerosis study (IRAS) family study. Diabetes. 2003;52(10):2490–2496. doi:10.2337/diabetes.52.10.2490
- Neeland IJ, Grundy SM, Li X, Adams-Huet B, Vega GL. Comparison of visceral fat mass measurement by dual-X-ray absorptiometry and magnetic resonance imaging in a multiethnic cohort: the dallas heart study. Nutr Diabetes. 2016;6(7):e221. doi:10.1038/nutd.2016.28
- Kaul S, Rothney MP, Peters DM, et al. Dual-energy x-ray absorptiometry for quantification of visceral fat. Obesity. 2012;20(6):1313–1318. doi:10.1038/oby.2011.393
- Manna P, Jain SK. Obesity, oxidative stress, adipose tissue dysfunction, and the associated health risks: causes and therapeutic strategies. Metab Syndr Relat Disord. 2015;13(10):423–444. doi:10.1089/met.2015.0095
- McMurray F, Patten DA, Harper ME. Reactive oxygen species and oxidative stress in obesity-recent findings and empirical approaches. Obesity (Silver Spring). 2016;24(11):2301–2310. doi:10.1002/oby.21654
- Ba X, Boldogh I. 8-Oxoguanine DNA glycosylase 1. Beyond repair of the oxidatively modified base lesions. Redox Biol. 2018;14:669–678. doi:10.1016/j.redox.2017.11.008
- Fujita K, Nishizawa H, Funahashi T, Shimomura I, Shimabukuro M. Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circ J. 2006;70(11):1437–1442. doi:10.1253/circj.70.1437
- Okauchi Y,K, Kishida K, Funahashi T, et al. Cross-sectional and longitudinal study of association between circulating thiobarbituric acid-reacting substance levels and clinic biochemical parameters in 1,178 middle-aged Japanese men - the Amagasaki visceral fat study. Nutr Metab (Lond). 2011;8(1):82. doi:10.1186/1743-7075-8-82
- Pou KM, Massaro JM, Hoffmann U, et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress. the Framingham heart study. Circulation. 2007;116(11):1234–1241. doi:10.1161/CIRCULATIONAHA.107.710509
- Nimse SB, Pal D. Free radicals, natural antioxidants, and their reaction mechanisms. RSC Adv. 2015;5(35):27986–28006. doi:10.1039/C4RA13315C
- Higuchi M, Dusting GJ, Peshavariya H, et al. Differentiation of human adipose-derived stem cells into fat involves reactive oxygen species and forkhead box O1 mediated upregulation of antioxidant enzymes. Stem Cells Dev. 2013;22(6):878–888. doi:10.1089/scd.2012.0306
- Xiao J, Lan L, Yi T, Rui W, Qiang L. The correlation between oxidative stress level and intra-abdominal fat in obese males. Medicine. 2019;98(7):e14469. doi:10.1097/MD.0000000000014469
- World Health Organization. Waist circumference and waist-hip ratio. Report of a WHO expert consultation, Geneva 8–11 December 2008. World Health Organization: Geneva; 2011
- WHO Study Group. Obesity: “preventing and managing the global epidemic. Report of a WHO consultation”. World Health Organ Tech Rep Ser. 2000;894:1–253.
- Carey RM, Whelton PK. 2017 ACC/AHA hypertension guideline writing committee. prevention, detection, evaluation, and management of high blood pressure in adults: synopsis of the 2017 American College of Cardiology/American Heart Association Hypertension guideline. Ann Intern Med. 2018;168(5):351–358. doi:10.7326/M17-3203
- American Diabetes Association. Classification and diagnosis of diabetes:standards of medical care in diabetes—2019. Diabetes Care. 2019;42(Supplement 1):S13–S28. doi:10.2337/dc19-S002
- National Institutes of Health ATP III. Guidelines at-a-glance quick desk reference. [Cited November 28, 2015.]. Available from: https://www.nhlbi.nih.gov/files/docs/guidelines/atglance.pdf.
- Wainson MG, Batterham AM, Tsakirides C, Rutherford ZH, Hind K. Prediction of whole-body fat percentage and visceral adipose tissue mass from five anthropometric variables. PLoS One. 2017;12(5):e0177175. doi:10.1371/journal.pone.0177175
- Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384(9945):766–781. doi:10.1016/S0140-6736(14)60460-8
- Rtveladze K, Marsh T, Barquera S, et al. Obesity prevalence in Mexico: impact on health and economic burden. Public Health Nutr. 2014;17(1):233–239. doi:10.1017/S1368980013000086
- Kim JA, Choi CJ, Yum KS. Cut-off values of visceral fat area and waist circumference: diagnostic criteria for abdominal obesity in a Korean population. J Korean Med Sci. 2006;21(6):1048–1053. doi:10.3346/jkms.2006.21.6.1048
- Tsukiyama H, Nagai Y, Matsubara F, et al. Proposed cut-off values of the waist circumference for metabolic syndrome based on visceral fat volume in a Japanese population. J Diabetes Investig. 2016;7(4):587–593. doi:10.1111/jdi.12454
- Miazgowski T, Kucharski R, Sołtysiak M, Taszarek A, Miazgowski B, Widecka K. Visceral fat reference values derived from healthy European men and women aged 20-30 years using GEhealthcare dual-energy x-ray absorptiometry. PLoS One. 2017;12(7):e0180614. doi:10.1371/journal.pone.0180614
- Tanaka H, Kokubo. Y. Epidemiology of obesity in Japan. JMAJ. 2005;48(1):34–41.
- Berghöfer A, Pischon T, Reinhold T, Apovian CM, Sharma AM, Willich SN. Obesity prevalence from a European perspective: a systematic review. BMC Public Health. 2008;8(1):200. doi:10.1186/1471-2458-8-200
- Ayala A, Muñoz MF, Argüelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014;2014:360438. doi:10.1155/2014/360438
- Abbasian M, Delvarianzadeh M, Ebrahimi H, Khosravi F, Nourozi P. Relationship between serum levels of oxidative stress and metabolic syndrome components. Diabetes Metab Syndr. 2018;12(4):497–500. doi:10.1016/j.dsx.2018.03.015
- Adnan MT, Amin MN, Uddin G, et al. Increased concentration of serum MDA, decreased antioxidants and altered trace elements and macro-minerals are linked to obesity among Bangladeshi population. Diabetes Metab Syndr. 2019;13(2):933–938. doi:10.1016/j.dsx.2018.12.022
- Lechuga AM, Gallego D, Ruiz P, et al. Obesity induced alterations in redox homeostasis and oxidative stress are present from an early age. PLoS One. 2018;13(1):e0191547. doi:10.1371/journal.pone.0191547
- Mutlu U, Oztezcan S, Telci A, et al. An increase in lipoprotein oxidation and endogenous lipid peroxides in serum of obese women. Clin Exp Med. 2003;2(4):171–174. doi:10.1007/s102380300002
- Yoshida Y, Umeno A, Shichiri M. Lipid peroxidation biomarkers for evaluating oxidative stress and assessing antioxidant capacity in vivo. J Clin Biochem Nutr. 2013;52(1):9–16. doi:10.3164/jcbn.12-112
- Czerska M, Zieliński M, Gromadzińska J. Isoprostanes - A novel major group of oxidative stress markers. Int J Occup Med Environ Health. 2015;29(2):179–190. doi:10.13075/ijomeh.1896.00596
- Davì G, Guagnano MT, Ciabattoni G, et al. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA. 2002;288(16):2008–2014. doi:10.1001/jama.288.16.2008
- Nobécourt E, Jacqueminet S, Hansel B, et al. Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia. Diabetologia. 2005;48(3):529–538. doi:10.1007/s00125-004-1655-5
- Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114(12):1752–1761. doi:10.1172/JCI21625
- Sjogren P, Basu S, Rosell M, et al. Measures of oxidized low-density lipoprotein and oxidative stress are not related and not elevated in otherwise healthy men with the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2005;25(12):2580–2586. doi:10.1161/01.ATV.0000190675.08857.3d
- Atawia RT, Bunch KL, Toque HA, Caldwell RB, Caldwell RW. Mechanisms of obesity-induced metabolic and vascular dysfunctions. Front Biosci (Landmark Ed). 2019;24(5):890–934. doi:10.2741/4758
- Douki T, Cadet J. Peroxynitrite mediated oxidation of purine bases of nucleosides and isolated DNA. Free Radic Res. 1996;24(5):369–380. doi:10.3109/10715769609088035
- Choi JW, Pai SH, Kim SK, Ito M, Park CS, Cha YN. Increases in nitric oxide concentrations correlate strongly with body fat in obese humans. Clin Chem. 2001;47(6):1106–1109. doi:10.1093/clinchem/47.6.1106
- Zahedi S, Ghasemi A, Azizi F. Serum nitric oxide metabolites in subjects with metabolic syndrome. Clin Biochem. 2008;41(16–17):1342–1347. doi:10.1016/j.clinbiochem.2008.08.076
- Gruber HJ, Mayer C, Mangge H, Fauler G, Grandits N, Wilders M. Obesity reduces the bioavailability of nitric oxide in juveniles. Int J Obes (Lond). 2008;32(5):826–831. doi:10.1038/sj.ijo.0803795
- Ferlito S, Gallina M. Nitrite plasma levels in type 1 and 2 diabetics with and without complications. Minerva Endocrinol. 1999;24(3–4):117–121.
- Klisic A, Kocic G, Kavaric N, Pavlovic R, Soldatovic I, Ninic A. Nitric oxide products are not associated with metabolic syndrome. J Med Biochem. 2019;38(3):361–367. doi:10.2478/jomb-2018-0035
- DeSouza CA, Van Guilder GP, Greiner JJ, Smith DT, Hoetzer GL, Stauffer BL. Basal endothelial nitric oxide release is preserved in overweight and obese adults. Obes Res. 2005;13(8):1303–1306. doi:10.1038/oby.2005.157
- Popko K, Gorska E, Stelmaszczyk-Emmel A, et al. Proinflammatory cytokines Il-6 and TNF-α and the development of inflammation in obese subjects. Eur J Med Res. 2010;15(S2):120–122. doi:10.1186/2047-783X-15-S2-120
- De Tursi L, Vázquez A, Vázquez A, Sáez G, Alí A, Gumbau V. Estrés oxidativo; estudio comparativo entre un grupo de población normal y un grupo de población obesa mórbida. Nutr Hosp. 2013;28(3):671–675. doi:10.3305/nh.2013.28.3.6355
- Cerdá C, Sánchez C, Climent B, et al. Oxidative stress and DNA damage in obesity-related tumorigenesis. Adv Exp Med Biol. 2014;824:5–17.
- Irigaray P, Belpomme D. Basic properties and molecular mechanisms of exogenous chemical carcinogens. Carcinogenesis. 2010;31(2):135–148. doi:10.1093/carcin/bgp252
- McAdam E, Brem R, Karran P. Oxidative stress-induced protein damage inhibits DNA repair and determines mutation risk and therapeutic efficacy. Mol Cancer Res. 2016;14(7):612–622. doi:10.1158/1541-7786.MCR-16-0053
- Sampath H, Vartanian V, Rollins MR, Sakumi K, Nakabeppu Y, Lloyd RS. 8-oxoguanine DNA glycosylase (OGG1) deficiency increases susceptibility to obesity and metabolic dysfunction. PLoS One. 2012;7(12):e51697. doi:10.1371/journal.pone.0051697
- Vincent HK, Powers SK, Stewart DJ, Shanely RA, Demirel H, Naito H. Obesity is associated with increased myocardial oxidative stress. Int J Obes Relat Metab Disord. 1999;23(1):67–74. doi:10.1038/sj.ijo.0800761
- Habib SA, Saad EA, Elsharkawy AA, Attia ZR. Pro-inflammatory adipocytokines, oxidative stress, insulin, Zn and Cu: interrelations with obesity in Egyptian non-diabetic obese children and adolescents. Adv Med Sci. 2015;60(2):179–185. doi:10.1016/j.advms.2015.02.002
- Amirkhizi F, Siassi F, Minaie S, Djalali M, Rahimi A, Chamari M. Is obesity associated with increased plasma lipid peroxidation and oxidative stress in women? ARYA Atheroscler. 2010;2:189–192.
- An H, Du X, Huang X, et al. Obesity, altered oxidative stress, and clinical correlates in chronic schizophrenia patients. Transl Psychiatry. 2018;8(1):258. doi:10.1038/s41398-018-0303-7
- Cruz S, Durán HH, Navarro M, Xochihua I, De la Peña S, Arroyo OE. Body mass index is associated with interleukin-1, adiponectin, oxidative stress and ioduria levels in healthy adults. Nutr Hosp. 2018;35(4):841–846. doi:10.20960/nh.1614
- Brown LA, Kerr CJ, Whiting P, Finer N, McEneny J, Ashton T. Oxidant stress in healthy normal-weight, overweight, and obese individuals. Obesity (Silver Spring). 2009;17(3):460–466. doi:10.1038/oby.2008.590
- Pulliam DA, Liu Y, Salmon AB. Dynamic differences in oxidative stress and the regulation of metabolism with age in visceral versus subcutaneous adipose. Redox Biol. 2015;6:401–408. doi:10.1016/j.redox.2015.07.014
- Ngo DTM, Sverdlov AL, Karki S, et al. Oxidative modifications of mitochondrial complex II are associated with insulin resistance of visceral fat in obesity. Am J Physiol Endocrinol Metab. 2019;316(2):E168–E77. doi:10.1152/ajpendo.00227.2018
- Kelli HM, Corrigan FE 3rd, Heinl RE, et al. Relation of changes in body fat distribution to oxidative stress. Am J Cardiol. 2017;120(12):2289–2293. doi:10.1016/j.amjcard.2017.08.053